[144 Pages Report] The China hemodialysis and peritoneal dialysis market is projected to grow from an estimated USD 5.0 billion in 2019 to USD 7.4 billion by 2024, at a CAGR of 8.5% during the forecast period. Market growth is largely driven by factors such as increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), and preference for dialysis treatments over kidney transplants due to lack of donors. Furthermore, rise in the number of dialysis centers across China coupled with the increasing interest of market players to expand their network in the country through the acquisition of dialysis facilities is adding growth opportunities to market.

By type, the hemodialysis segment is expected to be the largest contributor during the forecast period

On the basis of type, the dialysis market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment is further categorized into products (machines, & consumables/supplies) & services (in-center hemodialysis services and home hemodialysis (HHD) services). The peritoneal dialysis segment is further divided into products (machines & consumables) & services. The hemodialysis segment is expected to hold the largest share of the dialysis market in China as of 2019 mainly owing to greater accessibility of HD centers, growing number of community dialysis centers, higher physician expertise & awareness to administer HD, reimbursement coverage, and socio-demographic factors.

By end user, the in-center dialysis segment is expected to be the largest contributor to the China hemodialysis and peritoneal dialysis market

China dialysis market, by end user, is segmented into two categories�in-center dialysis and home dialysis. The in-center dialysis end-user segment is expected to hold the largest share of the dialysis end user market in China as of 2019; mainly due to the increasing number of dialysis centers across the globe, new product launches, and the availability of healthcare professionals in dialysis centers are propelling the growth of the in-center dialysis market.

Key Market Players

Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US) and Shandong Weigao Group Medical Polymer Company Limited (China) dominated the market. Other players in this market include B. Braun Melsungen AG (Germany), Nikkiso Co. Ltd. (Japan), DaVita Healthcare Partners, Inc (US), Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co., Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life Science and Technology Co. Ltd (China).

Fresenius Medical Care AG & Co. KGaA (Germany) is one of the leading players in the market. Its broad portfolio of dialysis products is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product launches, and contracts to maintain its top position. The company is also focused on providing training and conducting workshops to increase the adoption of its products.

Scope of the Report

Report Metric Details Market Size Available for Years 2017�2024 Base Year Considered 2018 Forecast Period 2019�2024 Forecast Units Value (USD) Segments Covered Type, Product Type, Modality, and End User Geographies Covered China Companies Covered Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Shandong Weigao Group Medical Polymer Company Limited (China), B. Braun Melsungen AG (Germany), Nikkiso Co. Ltd. (Japan), and DaVita Healthcare Partners, Inc (US), Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co., Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life Science and Technology Co. Ltd (China). Major 10 players covered.

This research report categorizes the China hemodialysis and peritoneal dialysis market based on type, product & services, modality, and end user.

China Hemodialysis Market

China Hemodialysis Market, by Products and Services

Hemodialysis Products Hemodialysis Machines Center-use Hemodialysis Machines Home-use Hemodialysis Machines Hemodialysis Consumables/Supplies Dialyzers Dialyzers Market, by Material Type Cellulose-based Dialyzer Synthetic Dialyzer Dialyzers market, by Flux Type High Flux Dialyzer Low Flux Dialyzer Hemodialysis Access Products Bloodlines Hemodialysis Concentrates/Dialysates

Hemodialysis Services In-center Hemodialysis Services Home Hemodialysis Services



Hemodialysis Market, by Modality

Conventional Hemodialysis

Short Daily Hemodialysis

Nocturnal Hemodialysis

China Peritoneal Dialysis Market

China Peritoneal Dialysis Market, By Products and Services

Peritoneal Dialysis Products Peritoneal Dialysis Concentrates/Dialysates Peritoneal Dialysis Machines Peritoneal Dialysis Catheters Peritoneal Dialysis Transfer Sets

Peritoneal Dialysis Services

Peritoneal Dialysis Market, by Modality

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Ambulatory Peritoneal Dialysis (APD)

China Hemodialysis and Peritoneal Dialysis Market, by End User

In-center Dialysis

Hospitals

Independent Dialysis Centers

Home Dialysis

Peritoneal Dialysis

Home Hemodialysis

Recent Developments

In 2018, Fresenius Medical Care acquired 70% shares of Guangzhou KangNiDaiSi Medical Investment Co., Ltd. company to expand its dialysis care network in China

In 2017, Fresenius Medical Care opened an independent dialysis center in Quanzhou (China). This expansion is aimed to increase access to dialysis treatment in the country.

In 2015, DaVita entered into a joint venture with Shunjing Renal Hospital (China) to establish DaVita (Shandong) Kidney Disease Hospital Co., Ltd. to increase its footprint in the China dialysis service market.

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of peritoneal dialysis across major areas of China in the future?

The reimbursement coverage and breakdown of overall costs for hemodialysis and peritoneal dialysis procedures in China?

Epidemiological trend, dialysis patient, and centers distribution across major regions of China?

Information regarding the clinical care process from how patients are diagnosed with ESRD, who is the key decision maker for using HD/PD, and what factors are involved for such decision made?

What are the new trends in the dialysis market of China?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst